期刊文献+

灯盏细辛注射液对代谢异常老年心脑血管事件及趋向预防干预初步研究 被引量:1

Preliminary Study of Dengzhan Xixin Injection on Prevention and Intervention of Cardiovascular and Cerebrovascular System Disease of Older People Caused by Metabolic Disorder
暂未订购
导出
摘要 目的观察灯盏细辛注射液对代谢异常老年心脑血管事件及趋向预防干预的效果。方法52例患者1种以上代谢异常老年干预组用灯盏细辛注射液30~40mL加入生理盐水250mL中静脉滴注,每日1次,10~14d为1个疗程,约隔半年1个周期,观察期3年以上。与50例对照组比较,观察两组症状、心脑血管事件及高敏C反应蛋白(hsCRP)值的变化。结果干预组的症状改善、心脑血管事件发生率及hsCRP值均优于对照组,相比差异有显著性意义(P<0.01)。结论灯盏细辛的预防干预可有效减少患有代谢异常老年人的心脑血管事件及阻遏其发生趋势。 Objective To observe the effect of Dengzhan Xixin injection on prevention and intervention of cardiovascular and cerebrovascular system disease of older people caused by metabolic disorder. Method A Group with metabolic syndrome were treated with a mixture of 30-40 mL of Dengzhan Xixin injection in 250 mL of physiological saline by intravenous injections (n=52). A treatment session was one injection once a day for 10-14 days. Each session was repeated every six months for a duration of three years. Cardiovascular and cerebrovascular disease symptoms, and changes of high sensitivity C-reactive protein (hsCRP) were measured compared with the control group (n=50). Results Compared to the control group, the intervention group had improved symptoms, lower occurrence of cardiovascular and cerebrovascular disease and ruduced hsCRP test result. The difference was significant (P〈0.01). Conclusion Prevention and treatment with Dengzhan Xixin injection effectively reduces or stops the prevalance of cardiovascular and cerebrovascular system disease symptoms in older people suffering from metabolic disorder.
出处 《中国中医药信息杂志》 CAS CSCD 2006年第6期17-18,共2页 Chinese Journal of Information on Traditional Chinese Medicine
关键词 灯盏细辛注射液 代谢异常 心脑血管事件 高敏C反应蛋白 预防干预 Dengzhan Xixin injection: metabolic disorder, high sensitivity C-reactive protein (hsCRP) the accident of cardiovascular and cerebrovascular system, prevention and intervention
  • 相关文献

参考文献6

  • 1Alexander CM,Landsman PB,Teutsch SM,et al.NCEP-defined metabolic syndrome,diabetes,and prevalence of coronary heart disease amongNHANESⅢ participants age 50 years and older[J].Diabetes,2003,52:1210-1214.
  • 2Ninomiya JK,L'Italien G,Criqui MH,et al.Association of the metabolic syndrome with history of myocardial infarction and stroke in the third National Health and Nutrition Examination Survey[J].Circulation,2004,109:42-46.
  • 3田慧,潘长玉,陆菊明,杜锦,徐向进,曹秀党.老年男性人群2型糖尿病与代谢综合征情况调查[J].中华老年多器官疾病杂志,2002,1(1):19-22. 被引量:23
  • 4Bulman N,Levy Y,Leiba R,et al.Increased C-reactive protein levels in the polycystic orary syndrome:a marker of cardiovascular disease[J].J Clin Endocrinol Metab,2004,89:2160.
  • 5王爱民,周颖,肖波,张智博.脑梗死患者血清高敏C反应蛋白水平的变化及其临床意义[J].临床神经病学杂志,2005,18(2):153-154. 被引量:132
  • 6Cornicelli JA,Trivedi BK.15-Lipoxygenase and its inhibition:a novel therapeutic target for vascular disease[J].Curr Pharm Des,1999,5(1):11-22.

二级参考文献9

  • 1田慧,潘长玉,陆菊明,孔祥涛,陆小平,姚晨,蒋赐恩,邓心新,王淑玉,朱艳,崔岚,王正升.糖代谢异常人群中冠心病、高血压的患病率及危险因素调查[J].中华内科杂志,1996,35(5):306-309. 被引量:18
  • 2[1]Reaven GM. Role of insulin resistance in human disease. Diabetes, 1988, 37:1595-1599.
  • 3[2]Marchesini G, Brizi M, Bianchi G,et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabe tes, 2001, 50: 1844-1850.
  • 4[3]Norman RJ, Kidson WJ, Cuneo RC, et al. Metformin and intervention in polycystic ovary syndrome. Endocrine Soci ety of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group. Med J Aust, 2001,174: 580-583.
  • 5[4]Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular mor bidity and mortality associated with the metabolic syn drome. Diabetes Care, 2001, 24: 683-689.
  • 6[8]Groop L, Orho-Melander M. The dysmetabolic syndrome, J Intem Med, 2001, 250: 105-120.
  • 7[9]Wilson SH, Kennedy FP, Garratt KN. Optimisation of themanagement of patients with coronary heart disease and type 2 diabetes mellitus. Drugs Aging, 2001, 18: 325-333.
  • 8马铁柱,万琪.脑梗死患者血浆炎症因子、纤溶活性的变化及对神经功能的影响[J].中国临床康复,2003,7(13):1875-1876. 被引量:56
  • 9郭毅,周志斌,姜昕,赵宏文,陈实,古坤毅,马可夫.急性脑梗死患者颈动脉斑块与血清C反应蛋白及白细胞计数的关系[J].临床神经病学杂志,2003,16(5):266-268. 被引量:137

共引文献153

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部